Biazacycloalkane-type menin-MLL protein inhibitor, pharmaceutical composition thereof and use thereof

TW202633649APending Publication Date: 2026-08-16SCINNOHUB PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143780
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2025-11-10
Publication Date
2026-08-16
Patent Text Reader

Abstract

The present disclosure provides biazacycloalkane compounds represented by Formula I and Formula II, pharmaceutically acceptable salts, hydrates, isomers, prodrugs thereof, or mixtures thereof, and pharmaceutical compositions comprising the same, and their use in the preparation of medicaments for the prevention, relief, or treatment of related diseases caused by Menin-MLL protein interactions.
Need to check novelty before this filing date? Find Prior Art